These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 12951490)
1. Intradermal concentration of hydroquinone after application of hydroquinone ointments is higher than its cytotoxic concentration. Matsubayashi T; Sakaeda T; Kita T; Kurimoto Y; Nakamura T; Nishiguchi K; Fujita T; Kamiyama F; Yamamoto A; Okumura K Biol Pharm Bull; 2003 Sep; 26(9):1365-7. PubMed ID: 12951490 [TBL] [Abstract][Full Text] [Related]
2. Effects of various storage conditions and alterations of antioxidant contents on chromatic aberration of hydroquinone ointment. Matsubayashi T; Sakaeda T; Kita T; Nakamura T; Kakumoto M; Funasaka Y; Ichihashi M; Fujita T; Kamiyama F; Yamamoto A; Nordlund JJ; Kaneko M; Iida A; Okumura K Biol Pharm Bull; 2003 Jan; 26(1):120-2. PubMed ID: 12520189 [TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical and clinical assessment of hydroquinone ointment prepared by extemporaneous nonsterile compounding. Matsubayashi T; Sakaeda T; Kita T; Nara M; Funasaka Y; Ichihashi M; Fujita T; Kamiyama F; Yamamoto A; Nordlund JJ; Kaneko M; Iida A; Hirai M; Okumura K Biol Pharm Bull; 2002 Jan; 25(1):92-6. PubMed ID: 11824565 [TBL] [Abstract][Full Text] [Related]
4. The percutaneous absorption of hydroquinone (HQ) through rat and human skin in vitro. Barber ED; Hill T; Schum DB Toxicol Lett; 1995 Oct; 80(1-3):167-72. PubMed ID: 7482585 [TBL] [Abstract][Full Text] [Related]
5. Risk assessment of skin lightening cosmetics containing hydroquinone. Matsumoto M; Todo H; Akiyama T; Hirata-Koizumi M; Sugibayashi K; Ikarashi Y; Ono A; Hirose A; Yokoyama K Regul Toxicol Pharmacol; 2016 Nov; 81():128-135. PubMed ID: 27521610 [TBL] [Abstract][Full Text] [Related]
6. Depigmentation with tert-butyl hydroquinone using black guinea pigs. Patrick E; Juberg DR; O'Donoghue J; Maibach HI Food Chem Toxicol; 1999; 37(2-3):169-75. PubMed ID: 10227740 [TBL] [Abstract][Full Text] [Related]
7. Enhanced stability and dermal delivery of hydroquinone using solid lipid nanoparticles. Ghanbarzadeh S; Hariri R; Kouhsoltani M; Shokri J; Javadzadeh Y; Hamishehkar H Colloids Surf B Biointerfaces; 2015 Dec; 136():1004-10. PubMed ID: 26579567 [TBL] [Abstract][Full Text] [Related]
8. Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis. Murakami T; Yoshioka M; Okamoto I; Yumoto R; Higashi Y; Okahara K; Yata N J Pharm Pharmacol; 1998 Jan; 50(1):55-61. PubMed ID: 9504435 [TBL] [Abstract][Full Text] [Related]
9. The co-drug of conjugated hydroquinone and azelaic acid to enhance topical skin targeting and decrease penetration through the skin. Hsieh PW; Al-Suwayeh SA; Fang CL; Lin CF; Chen CC; Fang JY Eur J Pharm Biopharm; 2012 Jun; 81(2):369-78. PubMed ID: 22469554 [TBL] [Abstract][Full Text] [Related]
10. Lack of nephrotoxicity and renal cell proliferation following subchronic dermal application of a hydroquinone cream. David RM; English JC; Totman LC; Moyer C; O'Donoghue JL Food Chem Toxicol; 1998 Jul; 36(7):609-16. PubMed ID: 9687968 [TBL] [Abstract][Full Text] [Related]
12. Effect of antioxidants on radical intensity and cytotoxicity of hydroquinone. Terasaka H; Takayama F; Satoh K; Fujisawa S; Sakagami H Anticancer Res; 2000; 20(5B):3357-62. PubMed ID: 11131635 [TBL] [Abstract][Full Text] [Related]
13. Analysis of in vitro skin permeation of 22-oxacalcitriol from ointments based on a two- or three-layer diffusion model considering diffusivity in a vehicle. Yamaguchi K; Mitsui T; Aso Y; Sugibayashi K Int J Pharm; 2007 May; 336(2):310-8. PubMed ID: 17240092 [TBL] [Abstract][Full Text] [Related]
14. The effect of oxygen tension on the cytotoxicity of hydroquinone and selected hydroquinone metabolites to isolated rat renal proximal tubular cells. Boatman RJ; English JC; Guerin TS; Cummings LM Arch Toxicol; 2004 Aug; 78(8):443-52. PubMed ID: 15083269 [TBL] [Abstract][Full Text] [Related]
15. S100B as a potential biomarker for the detection of cytotoxicity of melanocytes. Cheong KA; Noh M; Kim CH; Lee AY Exp Dermatol; 2014 Mar; 23(3):165-71. PubMed ID: 24451020 [TBL] [Abstract][Full Text] [Related]
16. Risk assessment of hydroquinone: differential responses of cell growth and lethality correlated to hydroquinone concentration. Kim YJ; Woo HD; Kim BM; Lee YJ; Kang SJ; Cho YH; Chung HW J Toxicol Environ Health A; 2009; 72(21-22):1272-8. PubMed ID: 20077196 [TBL] [Abstract][Full Text] [Related]
17. Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition. Wester RC; Melendres J; Hui X; Cox R; Serranzana S; Zhai H; Quan D; Maibach HI J Toxicol Environ Health A; 1998 Jun; 54(4):301-17. PubMed ID: 9638901 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and Characterization of a New Hydroquinone Derivative: Disodium p-Phenylene Diisostearyl Diphosphate. Hisama M; Matsuda S; Arai J; Masui K; Yamamura H J Oleo Sci; 2015; 64(9):1033-41. PubMed ID: 26329772 [TBL] [Abstract][Full Text] [Related]
20. Effect of emulsifiers and their liquid crystalline structures in emulsions on dermal and transdermal delivery of hydroquinone, salicylic acid and octadecenedioic acid. Otto A; Wiechers JW; Kelly CL; Dederen JC; Hadgraft J; du Plessis J Skin Pharmacol Physiol; 2010; 23(5):273-82. PubMed ID: 20484969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]